Unique ID issued by UMIN | UMIN000040823 |
---|---|
Receipt number | R000046603 |
Scientific Title | Safety evaluation of excessive consumption of the test food: an open-label trial |
Date of disclosure of the study information | 2020/11/01 |
Last modified on | 2021/01/04 09:11:06 |
Safety evaluation of excessive consumption of the test food
Safety evaluation of excessive consumption of the test food
Safety evaluation of excessive consumption of the test food: an open-label trial
Safety evaluation of excessive consumption of the test food
Japan |
Healthy Japanese subjects
Not applicable | Adult |
Others
NO
To identify the safety of excessive consumption of the test food
Safety
Confirmatory
Pragmatic
Not applicable
1. Incidence of side effects
2. Incidence of adverse events
1. Physical examination
2. Urinalysis
3. Blood test
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Duration: 4 weeks
Test food: Fermentation product of soy milk with lactic acid bacteria
20 | years-old | <= |
Not applicable |
Male and Female
1. Healthy Japanese adult subjects
2. Subject who does not become ill by consumption soy milk
3. Subjects who are judged as eligible to participate in the study by the physician
4. Select 11 subjects who defecate three to five times per week (constipation group) and 11 subjects who defecate more than five times per week (normal group)
5. The number of men and women is about the same
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction
2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD)
3. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, irritable bowel syndrome (IBS), or any other chronic diseases
4. Subjects regularly taking medications (including herbal medicines) and supplements
5. Subjects allergic to medications and/or soybeans
6. Subjects who are pregnant, lactating, or intending to become pregnant
7. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial
8. Subjects who are judged as ineligible to participate in the study by the physician
20
1st name | Kazuo |
Middle name | |
Last name | YAMAMOTO |
ORTHOMEDICO Inc.
CEO
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
kazu@orthomedico.jp
1st name | Naoko |
Middle name | |
Last name | SUZUKI |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
KIKKOMAN SOYFOODS COMPANY
Profit organization
Medical Corporation Seishinkai, Takara Clinic
the ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.
03-5793-3623
IRB@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
2020 | Year | 11 | Month | 01 | Day |
Unpublished
22
Completed
2020 | Year | 06 | Month | 10 | Day |
2020 | Year | 06 | Month | 10 | Day |
2020 | Year | 06 | Month | 18 | Day |
2020 | Year | 10 | Month | 03 | Day |
2020 | Year | 06 | Month | 18 | Day |
2021 | Year | 01 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046603